Singapore to get a new manufacturing, R&D site to fight help infectious diseases

Josh Sullivan

Hilleman Laboratories is opening a vaccine and biologics development hub in Singapore to aid the company’s journey to develop affordable vaccines against infectious diseases. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Singapore to get a new manufacturing, R&D site to fight help infectious diseases

Josh Sullivan

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Exclusive: First-of-its-kind infant DNA edit leads to apparent cure in disease that set back field 25 years ago

Updated: Galapagos to split into two companies, slash headcount as it eyes turnaround

MaaT Pharma touts ‘unprecedented’ Phase 3 efficacy of graft-versus-host disease treatment

Astellas stops developing autologous cell therapy using tech from Xyphos buyout

Gene editing startup Scribe Therapeutics lets go of staff as it preps for the clinic

Pfizer, GSK add risk of Guillain-Barré to RSV vaccine labels at FDA's request

Sin­ga­pore to get a new man­u­fac­tur­ing, R&D site to fight help in­fec­tious dis­eases

Sign up to read this article for free.

more like this

Bachem

Bubendorf, BL, Switzerland

Singapore to get a new manufacturing, R&D site to fight help infectious diseases